Details of the Drug

General Information of Drug (ID: DMYWRBV)

• Drug Name: CD19-targeted allogeneic T-cell therapy
• Synonyms: CD19-targeted allogeneic T-cell therapy (acute lymphoblastic leukemia)

Indication

Disease Entry	ICD 11	Status	REF
Acute lymphoblastic leukaemia	2A85	Phase 2	[1]

• Cross-matching ID: TTD ID: D0GR0I

References

• [1] CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Blood. 2015 Jun 25;125(26):4017-23.